January 17, 2020 – Lab Bioreagents, a biotechnology company developing assay reagents and kits to support drug development, today announced the raise of $2.7 million in financing to advance the development of assay buffers, kits and reagent services. Lab Bioreagents is pioneering high quality products and services in supporting the drug development programs.

We have a clear goal for Lab Bioreagents: provide assay buffers, biologics kits and reagent services in a world-class quality. There is a compelling need to improve the quality of reagents in biological assays. With the financial support, Lab Bioreagents is positioned to play a leading role improving the assay quality, shortening drug development timelines, and ultimately, supporting the sustainability of drug pipelines.